Much better to focus limited resources on the other opportunities in the portfolio IMHO.
My opinion too, and it was after CRL#1. Heart should of been the priority from the start. Back will be tricky and complex, can go either way, don't trust FDA. Heart we have a chance. My two bob!
CEO Itescu needs to go, page-765
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.035(3.17%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.15 | $1.08 | $3.273M | 2.947M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 95614 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 356483 | 25 |
View Market Depth
| Last trade - 15.21pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |